These receptors can directly bind circulating insulin to activate downstream signaling pathways, such as PI3K/AKT/mTOR and the Ras/MAPK/ERK pathways, to increase mitosis and therefore cancer cell proliferation and invasion (22–29). The gene discussed is AKT1; the disease is cancer.